Scientists track 10-Year protection of Single-Shot virus vaccine
NCT ID NCT04838444
Summary
This study is checking how long a single dose of an experimental chikungunya vaccine keeps protecting people and if it remains safe over many years. It follows about 375 adults who got the vaccine in a previous trial, checking their immunity and health annually for up to 10 years. The goal is to see if the vaccine provides lasting defense against the chikungunya virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA VIRUS INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Accelerated Enrollment Solutions (AES)
Phoenix, Arizona, 85020, United States
-
Accelerated Enrollment Solutions (AES)
Chicago, Illinois, 60602, United States
-
Alliance for Multispecialty Research (AMR)
Lexington, Kentucky, 40509, United States
-
Alliance for Multispecialty Research (AMR)
Knoxville, Tennessee, 37920, United States
-
Allliance for Multispecialty Research (AMR)
Norfolk, Virginia, 23502, United States
-
Velocity Clinical Research
Hallandale, Florida, 33090, United States
-
Velocity Clinical Research
Grand Island, Nebraska, 68803, United States
-
Velocity Clinical Research
Omaha, Nebraska, 68134, United States
-
Velocity Clinical Research
Austin, Texas, 78759, United States
-
Velocity Clinical Research
West Jordan, Utah, 84088, United States
Conditions
Explore the condition pages connected to this study.